Paula Vainio

Turku, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

Journal: BJUI compass

Published: June 18, 2026

Modelling targeted therapy efficacy in NRAS mutant conjunctival melanoma.

Modelling targeted therapy efficacy in NRAS mutant conjunctival melanoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 05, 2026

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Tumor cell FAP orchestrates EMT and immune suppression in aggressive localized ccRCC.

Journal: Theranostics

Published: May 28, 2025

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma.

Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma.

Journal: BJUI compass

Published: January 27, 2025

Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.

Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.

Journal: Oral oncology

Published: August 15, 2024

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth.

Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth.

Journal: Cell reports

Published: November 12, 2023

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.

Journal: Cancer medicine

Published: October 30, 2023

External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter study.

External validation of a deep learning-based algorithm for detection of tall cells in papillary thyroid carcinoma: A multicenter study.

Journal: Journal of pathology informatics

Published: September 25, 2023

Tumor-to-tumor metastasis to Warthin tumor presenting as an initial sign of breast carcinoma: A case report.

Tumor-to-tumor metastasis to Warthin tumor presenting as an initial sign of breast carcinoma: A case report.

Journal: Clinical case reports

Published: August 29, 2022

Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy.

Journal: Cancers

Published: November 27, 2021

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database.

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database.

Journal: Acta radiologica open

Published: May 23, 2021

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier.

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier.

Journal: Human pathology

Published: January 04, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026